Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 3 of 3 entries
Sorted by: Best Match Show Resources per page
Colorectal Cancer: New Aspects of Molecular Biology, Immunology and Clinical Applications. Proceedings of a conference. Berlin, Germany, October 8-9, 1999.

Annals of the New York Academy of Sciences

[No authors listed]
PMID: 10950746
Ann N Y Acad Sci. 2000 Jun;910:1-272.

No abstract available.

Immunogenomics of Colorectal Tumors: Facts and Hypotheses on an Evolving Saga.

Trends in cancer

Catalano I, Grassi E, Bertotti A, Trusolino L.
PMID: 31813455
Trends Cancer. 2019 Dec;5(12):779-788. doi: 10.1016/j.trecan.2019.10.006. Epub 2019 Nov 06.

Immunotherapy with immune checkpoint inhibitors is an approved treatment option for a subpopulation of patients with colorectal cancers that display microsatellite instability. However, not all individuals within this subgroup respond to immunotherapy, and molecular biomarkers for effective patient stratification...

An update on colorectal cancer microenvironment, epigenetic and immunotherapy.

International immunopharmacology

Jin K, Ren C, Liu Y, Lan H, Wang Z.
PMID: 33045561
Int Immunopharmacol. 2020 Dec;89:107041. doi: 10.1016/j.intimp.2020.107041. Epub 2020 Oct 09.

Colorectal cancer (CRC) is considered as the second most common cancer worldwide. For the past few years, the role of immunotherapy has been extensively studied and it has been demonstrated that its related approaches, such as programmed death-1 (PD-1)...

Showing 1 to 3 of 3 entries